The association between complement component 2/complement factor B polymorphisms and age-related macular degeneration: A HuGE review and meta-analysis

American Journal of Epidemiology

Volumn 176, Issue 5, 2012, Pages 361-372

  Thakkinstian, Ammarin ^a   McEvoy, Mark ^b   Chakravarthy, Usha ^c   Chakrabarti, Subhabrata ^d   McKay, Gareth J ^c   Ryu, Euijung ^e   Silvestri, Giuliana ^c   Kaur, Inderjeet ^d   Francis, Peter ^f   Iwata, Takeshi ^g   Akahori, Masakazu ^g   Arning, Astrid ^h   Edwards, Albert O ⁱ   Seddon, Johanna M ^j   Attia, John ^b,k  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d L V PRASAD EYE INSTITUTE   (India)

^e MAYO CLINIC   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^h Leibniz Institute of Arteriosclerosis Research   (Germany)

ⁱ UNIVERSITY OF OREGON   (United States)

^j TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k JOHN HUNTER HOSPITAL   (Australia)

more..

Author keywords

complement component factor 2; complement factor B; genetic association studies; genetics; genome, human; macular degeneration; meta analysis; molecular epidemiology

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C2;

ALLELE; EPIDEMIOLOGY; EYE DISEASE; GENETICS; GENOTYPE; HETEROGENEITY; META-ANALYSIS; MOLECULAR ANALYSIS; POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR;

ALLELE; EMBASE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; MEDLINE; META ANALYSIS; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

ASIAN CONTINENTAL ANCESTRY GROUP; COMPLEMENT C2; COMPLEMENT FACTOR B; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC MARKERS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MACULAR DEGENERATION; MODELS, STATISTICAL; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84865776603     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws031     Document Type: Review

References (65)

1. Klein ML, Schultz DW, Edwards A, et al. Age-related macular degeneration: clinical features in a large family and linkage to chromosome 1q. Arch Ophthalmol. 1998;116(8): 1082-1088.
2. Mitchell P, Smith W, Attebo K, et al. Prevalence of agerelated maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology. 1995;102(10):1450-1460.
3. Pang CP, Baum L, Chan WM, et al. The apolipoprotein E ε4 allele is unlikely to be a major risk factor of age-related macular degeneration in Chinese. Ophthalmologica. 2000;214(4):289-291.
4. VanNewkirk MR, Nanjan MB, Wang JJ, et al. The prevalence of age-related maculopathy: the Visual Impairment Project. Ophthalmology. 2000;107(8):1593- 1600.
5. Evans J, Wormald R. Is the incidence of registrable agerelated macular degeneration increasing? Br J Ophthalmol. 1996;80(1):9-14.
6. Schmidt S, Klaver C, Saunders A, et al. A pooled casecontrol study of the apolipoprotein E (APOE) gene in agerelated maculopathy. Ophthalmic Genet. 2002;23(4):209-223.
7. Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995;102(2):205-210.
8. Rivera A, Fisher SA, Fritsche LG, et al. Hypothetical LOC387715 is a second major susceptibility gene for agerelated macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet. 2005;14(21):3227-3236.
9. Conley YP, Jakobsdottir J, Mah T, et al. CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to agerelated maculopathy: AREDS and CHS cohorts and metaanalyses. Hum Mol Genet. 2006;15(21):3206-3218.
10. Despriet DD, Klaver CC, Witteman JC, et al. Complement factor H polymorphism, complement activators, and risk of agerelated macular degeneration. JAMA. 2006;296(3):301-309.
11. Thakkinstian A, Han P, McEvoy M, et al. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum Mol Genet. 2006;15(18):2784-2790.
12. Kaur I, Katta S, Hussain A, et al. Variants in the 10q26 gene cluster (LOC387715 and HTRA1) exhibit enhanced risk of age-related macular degeneration along with CFH in Indian patients. Invest Ophthalmol Vis Sci. 2008;49(5):1771-1776.
13. Maller J, George S, Purcell S, et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet. 2006;38(9):1055-1059.
14. Maller JB, Fagerness JA, Reynolds RC, et al. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet. 2007;39(10):1200-1201.
15. Bergeron-Sawitzke J, Gold B, Olsh A, et al. Multilocus analysis of age-related macular degeneration. Eur J Hum Genet. 2009;17(9):1190-1199.
16. Cui L, Zhou H, Yu J, et al. Noncoding variant in the complement factor H gene and risk of exudative age-related macular degeneration in a Chinese population. Invest Ophthalmol Vis Sci. 2010;51(2):1116-1120.
17. Despriet DD, van Duijn CM, Oostra BA, et al. Complement component C3 and risk of age-related macular degeneration. Ophthalmology. 2009;116(3):474.e2-480. e2.
18. Edwards AO, Fridley BL, James KM, et al. Evaluation of clustering and genotype distribution for replication in genome wide association studies: the Age-Related Eye Disease Study. PLoS One. 2008;3(11):e3813. (doi:10.1371/journal. pone.0003813).
19. Francis PJ, Hamon SC, Ott J, et al. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss. J Med Genet. 2009;46(5):300-307.
20. Goto A, Akahori M, Okamoto H, et al. Genetic analysis of typical wet-type age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese population. J Ocul Biol Dis Infor. 2009;2(4):164-175.
21. Gu J, Pauer GJ, Yue X, et al. Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers. Mol Cell Proteomics. 2009;8(6): 1338-1349.
22. Park KH, Fridley BL, Ryu E, et al. Complement component 3 (C3) haplotypes and risk of advanced age-related macular degeneration. Invest Ophthalmol Vis Sci. 2009;50(7): 3386-3393.
23. Pei XT, Li XX, Bao YZ, et al. Association of c3 gene polymorphisms with neovascular age-related macular degeneration in a Chinese population. Curr Eye Res. 2009; 34(8):615-622.
24. Reynolds R, Hartnett ME, Atkinson JP, et al. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci. 2009;50(12): 5818-5827.
25. Scholl HP, Fleckenstein M, Fritsche LG, et al. CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD. PLoS One. 2009;4(10):e7418. (doi:10.1371/journal. pone.0007418).
26. Scholl HP, Charbel Issa P, Walier M, et al. Systemic complement activation in age-related macular degeneration. PLoS One. 2008;3(7):e2593. (doi:10.1371/journal. pone.0002593).
27. Seddon JM, Reynolds R, Maller J, et al. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci. 2009;50(5):2044-2053.
28. Seitsonen SP, Onkamo P, Peng G, et al. Multifactor effects and evidence of potential interaction between complement factor H Y402H and LOC387715 A69S in age-related macular degeneration. PLoS One. 2008;3(12):e3833. (doi:10.1371/journal.pone.0003833).
29. Spencer KL, Olson LM, Anderson BM, et al. C3 R102G polymorphism increases risk of age-related macular degeneration. Hum Mol Genet. 2008;17(12):1821-1824.
30. Yates JR, Sepp T, Matharu BK, et al. Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med. 2007;357(6):553-561.
31. Farwick A, Dasch B, Weber BH, et al. Variations in five genes and the severity of age-related macular degeneration: results from the Muenster Aging and Retina Study. Eye (Lond). 2009;23(12):2238-2244.
32. Gold B, Merriam JE, Zernant J, et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet. 2006; 38(4):458-462.
33. Jakobsdottir J, Conley YP, Weeks DE, et al. C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes. PLoS One. 2008;3(5):e2199. (doi:10.1371/journal.pone.0002199).
34. McKay GJ, Silvestri G, Patterson CC, et al. Further assessment of the complement component 2 and factor B region associated with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2009;50(2):533-539.
35. Richardson AJ, Amirul Islam FM, Guymer RH, et al. Analysis of rare variants in the complement component 2 (C2) and factor B (BF) genes refine association for agerelated macular degeneration (AMD). Invest Ophthalmol Vis Sci. 2009;50(2):540-543.
36. Spencer KL, Hauser MA, Olson LM, et al. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum Mol Genet. 2007;16(16):1986-1992.
37. Kaur I, Katta S, Reddy RK, et al. The involvement of complement factor B and complement component C2 in an Indian cohort with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2010;51(1):59-63.
38. Thakkinstian A, McKay GJ, McEvoy M, et al. Systematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol. 2011;173(12):1365-1379.
39. Thakkinstian A, Thompson JR, Minelli C, et al. Choosing between per-genotype, per-allele, and trend approaches for initial detection of gene-disease association. J Appl Stats. 2009;36(6):633-646.
40. Thakkinstian A, McEvoy M, Minelli C, et al. Systematic review and meta-analysis of the association between β2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol. 2005;162(3):201-211.
41. Thompson JR, Minelli C, Abrams KR, et al. Meta-analysis of genetic studies using Mendelian randomization-a multivariate approach. Stat Med. 2005;24(14):2241-2254.
42. Thompson SG. Why sources of heterogeneity in metaanalysis should be investigated. BMJ. 1994;309(6965): 1351-1355.
43. Thompson SG, Sharp SJ. Explaining heterogeneity in metaanalysis: a comparison of methods. Stat Med. 1999;18(20): 2693-2708.
44. Thompson SG, Smith TC, Sharp SJ. Investigating underlying risk as a source of heterogeneity in meta-analysis. Stat Med. 1997;16(23):2741-2758.
45. Minelli C, Thompson JR, Abrams KR, et al. The choice of a genetic model in the meta-analysis of molecular association studies. Int J Epidemiol. 2005;34(6):1319-1328.
46. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634.
47. Palmer TM, Peter JL, Sutton AJ, et al. Contour-enhanced funnel plots in meta-analysis. STATA J. 2008;8(2):242-254.
48. Peters JL, Sutton AJ, Jones DR, et al. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 2008; 61(10):991-996.
49. Duval S, Tweedie R. Trim and fill: a simple funnelplot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455-463.
50. Hayden KM, Zandi PP, Lyketsos CG, et al. Apolipoprotein E genotype and mortality: findings from the Cache County Study. J Am Geriatr Soc. 2005;53(6):935-942.
51. Rossman MD, Thompson B, Frederick M, et al. HLADRB1* 1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet. 2003;73(4):720-735.
52. StataCorp LP. Stata Statistical Software: Release 11.0. College Station, TX: StataCorp LP; 2009.
53. Spiegelhalter D, Thomas A, Best N, et al. WinBUGS User Manual. Cambridge, United Kingdom: MRC Biostatistics Unit, Institute of Public Health, University of Cambridge; 2007.
54. Chen Y, Zeng J, Zhao C, et al. Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors. Arch Ophthalmol. 2011;129(3): 344-351.
55. Liu X, Zhao P, Tang S, et al. Association study of complement factor H, C2, CFB, and C3 and age-related macular degeneration in a Han Chinese population. Retina. 2010;30(8):1177-1184.
56. Chu J, Zhou CC, Lu N, et al. Genetic variants in three genes and smoking show strong associations with susceptibility to exudative age-related macular degeneration in a Chinese population. Chin Med J (Engl). 2008;121(24): 2525-2533.
57. Ioannidis JP, Ntzani EE, Trikalinos TA. 'Racial' differences in genetic effects for complex diseases. Nat Genet. 2004;36(12):1312-1318.
58. Clarke GM, Cardon LR. Aspects of observing and claiming allele flips in association studies. Genet Epidemiol. 2010;34 (3):266-274.
59. Zaykin DV, Shibata K. Genetic flip-flop without an accompanying change in linkage disequilibrium [letter]. Am J Hum Genet. 2008;82(3):794-796.
60. Lin PI, Vance JM, Pericak-Vance MA, et al. No gene is an island: the flip-flop phenomenon. Am J Hum Genet. 2007;80(3):531-538.
61. Yu Y, Bhangale TR, Fagerness J, et al. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet. 2011;20(18):3699-3709.
62. Little J, Higgins J, eds. The HuGENet™ HuGE Review Handbook, Version 1.0. Ottawa, Ontario, Canada: University of Ottawa; 2006.
63. Heurich M, Martínez-Barricarte R, Francis NJ, et al. Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk. Proc Natl Acad Sci USA. 2011;108(21):8761-8766.
64. Montes T, Tortajada A, Morgan BP, et al. Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B. Proc Natl Acad Sci USA. 2009;106(11):4366-4371.
65. Seddon JM, Sharma S, Adelman RA. Evaluation of the Clinical Age-Related Maculopathy Staging System. Ophthalmology. 2006;113(2):260-266.